In addition, the concentration-dependent inhibitory properties of the prepared PDA@CNTs on the activity of the alpha glucosidase enzyme showed their possible use as a drug in the treatment of Type 2 diabetes. The gene discussed is GAA; the disease is type 2 diabetes mellitus.